These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 14097615)

  • 1. [VACCINES IN PREVENTING STREPTOCOCCAL DISEASES].
    WEISGLASS H
    Lijec Vjesn; 1963 Oct; 85():1105-16. PubMed ID: 14097615
    [No Abstract]   [Full Text] [Related]  

  • 2. [Behavior of antistreptolysin in scarlatinal infections treated with streptococcal vaccine].
    RECCHIA F; RAVAZZONI L
    Boll Ist Sieroter Milan; 1956; 35(5-6):243-54. PubMed ID: 13342188
    [No Abstract]   [Full Text] [Related]  

  • 3. [An rare complication of scarlet fever : invasive group A streptococcal infection with streptococcal toxic shock syndrome].
    Warnier H; Depuis Z; Nyamugabo K; Desprechins B; Seghaye MC
    Rev Med Liege; 2017 Mar; 72(3):132-137. PubMed ID: 28387490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Streptococcal infections and scarlet fever.
    HARRIS PL
    Ohio State Med J; 1948 Aug; 44(8):812. PubMed ID: 18877741
    [No Abstract]   [Full Text] [Related]  

  • 5. [Importance of Streptococci for scarlet fever and rheumatic fever].
    KUSTER F
    Dtsch Med J; 1957 Mar; 8(3):115-21. PubMed ID: 13427587
    [No Abstract]   [Full Text] [Related]  

  • 6. The role of antistreptolysin in scarlet fever and some other infectious diseases.
    LAGERCRANTZ R
    Scand J Clin Lab Invest; 1950; 2(2):152-61. PubMed ID: 15424638
    [No Abstract]   [Full Text] [Related]  

  • 7. [Malignant scarlet fever syndrome with hemolytic streptococcus peritonitis].
    LOWYS P
    J Med Lyon; 1947 May; 28(656):353. PubMed ID: 20343235
    [No Abstract]   [Full Text] [Related]  

  • 8. [Epidemiology and prevention of streptococcal infections].
    Ivan A; Groll M; Buzdugan I; Mitroi I
    Rev Med Chir Soc Med Nat Iasi; 1989; 93(1):61-5. PubMed ID: 2814031
    [No Abstract]   [Full Text] [Related]  

  • 9. The immune cellular response tested by lymphocyte transformation in the streptococcal infections.
    Mihalcu F; Stefănescu ?M; Teodorescu ?M
    Dev Biol Stand; 1975; 28():246-50. PubMed ID: 1126571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of types of treatment on development of antistreptolysin in patients with scarlet fever.
    WEINSTEIN L; TSAO CC
    Proc Soc Exp Biol Med; 1946 Nov; 63(2):449. PubMed ID: 20277780
    [No Abstract]   [Full Text] [Related]  

  • 11. [Beta-hemolytic streptococci in the level of the infantile genitalia during scarlet fever].
    MALEK J
    Schweiz Med Wochenschr; 1948 May; 78(17):402-4. PubMed ID: 18934615
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of administration of Streptococcus salivarius K12 on the occurrence of streptococcal pharyngo-tonsillitis, scarlet fever and acute otitis media in 3 years old children.
    Di Pierro F; Colombo M; Giuliani MG; Danza ML; Basile I; Bollani T; Conti AM; Zanvit A; Rottoli AS
    Eur Rev Med Pharmacol Sci; 2016 Nov; 20(21):4601-4606. PubMed ID: 27874935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Preparation of streptococcal antigens for the complement fixation test. Diagnostic use in subjects with streptococcal diseases].
    Milli G; Trevisan C; Iacomelli L
    G Ig Med Prev; 1969 Dec; 10(5):541-51. PubMed ID: 5403784
    [No Abstract]   [Full Text] [Related]  

  • 14. [Scarlet fever and other infections from Streptococcus pyogenes].
    Med Monatsschr Pharm; 2001 Mar; 24(3):83-6. PubMed ID: 11291694
    [No Abstract]   [Full Text] [Related]  

  • 15. [Epidemiologic characteristics of streptococcal pharyngitis, scarlatina and rheumatic fever in the area of Belgrade 1981-1987].
    Bukumirović K
    Srp Arh Celok Lek; 1990; 118(9-10):393-6. PubMed ID: 2102556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Septic scarlet fever due to Streptococcus pyogenes cellulitis.
    Shaunak S; Wendon J; Monteil M; Gordon AM
    Q J Med; 1988 Nov; 69(259):921-5. PubMed ID: 3078213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Epidemiological, immunological & microbiological characteristics of streptococcal infection in collectives (scarlatina & carrier of hemolytic streptococci)].
    PERVACHENKO SV
    Pediatriia; 1959 Feb; 14(2):28-33. PubMed ID: 13645153
    [No Abstract]   [Full Text] [Related]  

  • 18. [Once again scarlet fever and streptococcal culture neurosis].
    Daschner F
    Monatsschr Kinderheilkd; 1989 Aug; 137(8):472-3. PubMed ID: 2682213
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical picture and evolution of scarlet fever due to beta hemolytic group streptococcus].
    Stefanović N; Najdanović Lj; Krajinović S; Nastasović M; Vlajinać H
    Srp Arh Celok Lek; 1978 Sep; 106(9):807-14. PubMed ID: 380014
    [No Abstract]   [Full Text] [Related]  

  • 20. [TYPES OF PYOGENIC STREPTOCOCCI IN RELATION TO THE ENDEMO-EPIDEMICITY OF SCARLATINA IN RUMANIA DURING THE 1945-1962 PERIOD].
    BALDOVIN-AGAPI C; MIHALCO F; GHEORGHIU M
    Arch Roum Pathol Exp Microbiol; 1963 Sep; 23():551-6. PubMed ID: 14167386
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.